PT  - JOURNAL ARTICLE
AU  - Miller, Ian F.
AU  - Metcalf, C. Jessica E.
TI  - No current evidence for risk of vaccine-driven virulence evolution in SARS-CoV-2
AID  - 10.1101/2020.12.01.20241836
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.12.01.20241836
4099  - http://medrxiv.org/content/early/2020/12/03/2020.12.01.20241836.short
4100  - http://medrxiv.org/content/early/2020/12/03/2020.12.01.20241836.full
AB  - Vaccines that reduce clinical severity but not infection or transmission could drive the evolution of increased rates of pathogen-inflicted damage, or virulence. Preliminary evidence suggests that COVID-19 vaccines might have such differential effects, conferring greater protection in the lower respiratory tract, where viral growth most impacts severity, than in the upper respiratory tract, where infection is chiefly determined. However, the evolution of increased virulence can only occur under certain conditions, which include the existence of a positive association between transmission and severity linked to viral genetic variation. Here, we review the current evidence for these conditions, which does not point to a risk of vaccine driven virulence evolution. An evo-epidemiological model also indicates that upper respiratory tract protection can minimize or negate selection for increased virulence should these conditions be met. Despite low apparent risks, SARS-CoV-2 virulence should be monitored, and transmission-limiting characteristics should be prioritized for ‘second-wave’ vaccines.Competing Interest StatementThe authors have declared no competing interest.Funding StatementIFM is supported by a NSF Graduate Research Fellowship.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:n/aAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll code used to perform the analyses presented in this manuscript is available on GitHub. https://github.com/ianfmiller/covid_vaccines_virulence_evolution